PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Leptospermum scoparium, known as mānuka, is a shrub native to New Zealand and Australia used to produce mānuka oil and honey, both of which exhibit significant antimicrobial and anti-inflammatory properties [PMID:33114724, PMID:37282661].
Background
Leptospermum scoparium is a culturally and economically significant shrub species native to New Zealand and Australia [PMID:35039864]. It is the floral source for mānuka honey, a dark monofloral honey [PMID:31294240].
Traditional uses
The plant has been used by the indigenous populations of New Zealand and Australia for centuries [PMID:33114724]. Honey has been used in many cultures as a remedy for burns, cataracts, ulcers, and wound healing [PMID:28234328].
Active compounds
Key compounds include methylglyoxal (MGO) and its precursor dihydroxyacetone (DHA) [PMID:31294240, PMID:28407946]. The essential oil contains $\beta$-triketones (flavesone, leptospermone, and isoleptospermone) [PMID:39752786], calamenene [PMID:32078653], and grandiflorone [PMID:38338460]. Other identified components include 3,6,7-trimethyllumazine (Lepteridine™) [PMID:38002130], phenylpropanoyl phloroglucinol derivatives (Leptosperols C-G) [PMID:36546830], and phenolic compounds [PMID:31294240].
Mechanism of action
MGO and DHA inhibit jack bean urease activity [PMID:28407946]. $\beta$-triketones in the oil act as inhibitors of the tyrosine catabolism pathway by inhibiting hydroxyphenylpyruvate dioxygenase (HPPD) [PMID:39752786]. Lepteridine™ inhibits the gelatinase activities of matrix metalloproteinase 9 (MMP-9) [PMID:38002130]. Chloroform extracts have been shown to induce apoptosis in HepG2 and MCF-7 cancer cells by upregulating mRNA levels of P53, Bax, and caspases while decreasing Bcl-2 mRNA [PMID:39101096].
Clinical evidence
Evidence ADry eye
Treatment with manuka honey demonstrated a significant improvement in symptoms and tear film quality [PMID:35950413].
Evidence CWound healing (chronic and postoperative)
Manuka honey demonstrates broad-spectrum antimicrobial and antibiofilm effects, reduces bacterial load, and promotes granulation and re-epithelialisation [PMID:42117760].
Evidence CAllergy and allergic rhinitis
Manuka honey is cited as one of the therapies with the strongest evidence for treatment [PMID:36088149].
Safety & adverse effects
Manuka honey is described as likely completely safe with no known side effects [PMID:36088149].
Drug interactions
Manuka honey has demonstrated the ability to enhance the effectiveness of antibiotics when used in combination [PMID:37282661].
Evidence summary
Evidence ranges from high-level meta-analyses for specific conditions like dry eye to in vitro and animal model studies for antimicrobial and anticancer properties. Clinical evidence for wound care and allergies is based on reviews.
PubMed sources
- 1.PMID: 31294240 (2018) — Antibacterial activity of Manuka honey and its components: An overview. · AIMS microbiology
- 2.PMID: 36088149 (2022) — Allergies and Natural Alternatives. · Otolaryngologic clinics of North America
- 3.PMID: 11114000 (2000) — Pharmacological and antimicrobial studies on different tea-tree oils (Melaleuca alternifolia, Leptospermum scoparium or Manuka and Kunzea ericoides or Kanuka), originating in Australia and New Zealand. · Phytotherapy research : PTR
- 4.PMID: 33388180 (2021) — Proteomic analysis of honey. Identification of unique peptide markers for authentication of NZ mānuka (Leptospermum scoparium) honey. · Food chemistry
- 5.PMID: 39752786 (2025) — β-Triketones from Leptospermum scoparium (mānuka) oil show potential as scabicides.